SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ENTX

Entera Bio Ltd.
NASDAQHealth Care

Latest close: 2.68 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 18, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 7, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record38410 flagged findings
Reported transactions (Form 4)80since Apr 24, 2023 · and 11 other holdings
Corporate events (8-K)22since May 16, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-07share offering or dilution eventfreshOpen filing ↗
    “…may use our available capital resources sooner than currently anticipated. Equity Offerings On September 2, 2022, we entered into a…”
    +1 more passage from the same document
    • “…and costs of our development programs and other operating activities. These assumptions are subject to change, and we may use…”
  • 2026-07-28share offering or dilution eventfreshOpen filing ↗
    “…Shares. The Pre-Funded Warrants may not be exercised if the aggregate number of Ordinary Shares beneficially owned by the holder…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 384)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 14, 26DEF 14A ↗Shareholder meeting and votes new
  • Oct 6, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 23, 26PRE 14A ↗Shareholder meeting and votes
  • Aug 28, 26424B3 ↗Securities offering
  • Aug 21, 26S-3 ↗Securities offering
  • Aug 21, 26Form 3 ↗Insider transaction
  • Aug 18, 268-K ↗Current report · Communication to the market · Other events
  • Insider transaction · 9 Form 4 filingsshow all 9hide
  • Aug 7, 2610-Q ↗Quarterly report
  • Aug 7, 268-K ↗Current report · Results · Communication to the market
  • Aug 4, 26SCHEDULE 13G ↗Passive stake · Vivo Opportunity, LLC · 6.9% · event on Jul 28, 26
  • Aug 4, 26SCHEDULE 13G ↗Passive stake · Longitude Capital Partners V, LLC · 4.6% · event on Jul 28, 26
  • Aug 4, 26SCHEDULE 13G ↗Passive stake · TCG Crossover GP III, LLC · 7.1% · event on Jul 28, 26
  • Aug 4, 26SCHEDULE 13G ↗Passive stake · Seven Fleet Capital Management LP · 4.1% · event on Jul 28, 26
  • Aug 4, 26SCHEDULE 13D ↗Stake with intent to influence · BVF PARTNERS L P/IL · 10.0% · event on Jul 28, 26
  • Jul 28, 268-K ↗Current report · Entered a material agreement
  • Jul 16, 268-K ↗Current report · A senior executive left or was appointed

384 filings on record, the oldest from May 1, 15.

Listing the 25 most recent filings of the 384 on record.

8-Ks, explained

Stress2Structure11Governance9
  • Oct 6, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 28, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 16, 26GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Apr 3, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 9, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 4, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 17, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Dec 26, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 30, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 7, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 23, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 2, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

4 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • BVF PARTNERS L P/IL10.0%Jul 28, 26SCHEDULE 13D ↗10 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • OPKO HEALTH, INC.8.1%Mar 16, 25SCHEDULE 13G ↗
  • TCG Crossover GP III, LLC7.1%Jul 28, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Vivo Opportunity, LLC6.9%Jul 28, 26SCHEDULE 13G ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
  • Longitude Capital Partners V, LLC4.6%Jul 28, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Seven Fleet Capital Management LP4.1%Jul 28, 26SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
show one more holderhide
  • Point72 Asset Management, L.P.2.6%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Mar 9, 26Buy$26KGeno J Germano↗
  • Mar 5, 26Buy$12KSean Ellis↗
  • Feb 12, 26Buy$7KSteven D Rubin↗
  • Feb 10, 26Buy$30KGeno J Germano↗
  • Feb 10, 26Buy$11KHaya Taitel↗
  • Feb 9, 26Buy$22KSean Ellis↗
  • Feb 9, 26Buy$12KSteven D Rubin↗
  • Dec 29, 25Buy$20KMiranda Jayne ToledanoChief Executive Officer↗
Stock compensation, tax and giftsshow the 32 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 7, 26Compensationamount n/aGeno J Germano↗
  • Aug 7, 26Compensationamount n/aSean Ellis↗
  • Aug 7, 26Compensationamount n/aHaya Taitel↗
  • Aug 7, 26Compensationamount n/aYonatan Malca↗
  • Aug 7, 26Compensationamount n/aSteven D Rubin↗
  • Jul 14, 26Compensationamount n/aMiranda Jayne ToledanoChief Executive Officer↗
  • Jul 14, 26Compensationamount n/aMiranda Jayne ToledanoChief Executive Officer↗
  • May 7, 26Compensationamount n/aGregory BurshteinChief of R&D↗
  • May 7, 26Compensationamount n/aDana Yaacov-GarbeliChief Financial Officer↗
  • May 7, 26Compensationamount n/aHillel GalitzerChief Operating Officer↗
  • Jan 1, 26Compensationamount n/aHaya Taitel↗
  • Jan 1, 26Compensationamount n/aGERALD M LIEBERMAN↗
  • Jan 1, 26Compensationamount n/aYonatan Malca↗
  • Jan 1, 26Compensationamount n/aSean Ellis↗
  • Jan 1, 26Compensationamount n/aGERALD M OSTROV↗
  • Jul 16, 25Compensationamount n/aDana Yaacov-GarbeliChief Financial Officer↗
  • Jul 16, 25Compensationamount n/aGregory BurshteinChief of R&D↗
  • Jul 16, 25Compensationamount n/aMiranda Jayne ToledanoChief Executive Officer↗
  • Jul 16, 25Compensationamount n/aMiranda Jayne ToledanoChief Executive Officer↗
  • Apr 28, 25Compensationamount n/aHillel GalitzerChief Operating Officer↗
  • Apr 1, 25Compensation$24KGERALD M LIEBERMAN↗
  • Jan 15, 25Compensationamount n/aSean Ellis↗
  • Jan 15, 25Compensationamount n/aGERALD M LIEBERMAN↗
  • Jan 15, 25Compensationamount n/aYonatan Malca↗
  • Jan 15, 25Compensationamount n/aGERALD M OSTROV↗
  • Jan 15, 25Compensationamount n/aHaya Taitel↗
  • Oct 2, 24Compensationamount n/aSean Ellis↗
  • Oct 2, 24Compensationamount n/aGERALD M LIEBERMAN↗
  • Oct 2, 24Compensationamount n/aYonatan Malca↗
  • Oct 2, 24Compensationamount n/aGERALD M OSTROV↗
  • Oct 2, 24Compensationamount n/aHaya Taitel↗
  • Aug 27, 24Compensationamount n/aGERALD M LIEBERMAN↗

The full record holds 55 transactions and goes back to Jan 2, 23.

Its sector and its market

Entera Bio Ltd. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Entera Bio Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Entera Bio Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
384 documents on file, from May 1, 2015 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Entera Bio Ltd. (ENTX): stock price history, insider trades and SEC filings — HornScout